DuPont de Nemours, Inc. (DD) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary presents mixed signals. Positive elements include strong margins, productivity gains, and strategic positioning in the healthcare and automotive segments. However, concerns arise from flat organic sales, construction market weakness, and uncertainties related to Middle East logistics. The Q&A section revealed management's avoidance of addressing potential demand destruction. These factors balance out, suggesting a neutral stock price reaction.
Key Financial Performance
Net Sales $1.7 billion, up 4% year-over-year (2% organic sales growth and 2% benefit from currency). Growth driven by strength in healthcare and aerospace, partially offset by softness in construction markets and logistics disruptions due to the Middle East conflict.
Operating EBITDA $414 million, up 15% year-over-year. Margin expanded to 24.6%, an increase of 230 basis points. Growth attributed to organic sales growth, favorable mix, and productivity.
Transaction-Adjusted Free Cash Flow $147 million with a conversion rate of 65%. No specific reasons for change mentioned.
Adjusted EPS $0.55, up 53% year-over-year. On a pro-forma basis, adjusted EPS increased 20%, driven by higher segment earnings, lower tax rate, share count, and exchange gains and losses.
Healthcare & Water Technologies Net Sales $806 million, up 6% year-over-year (3% organic growth and 3% benefit from currency). Growth led by strength in medical packaging and biopharma, partially offset by logistics disruptions in the Middle East.
Healthcare & Water Technologies Operating EBITDA $244 million, up 9% year-over-year. Margin increased to 30.3%, an increase of 110 basis points. Growth driven by organic growth, favorable mix, and productivity gains.
Diversified Industrials Net Sales $875 million, up 3% year-over-year (3% benefit from currency). Organic sales were flat. Growth in aerospace and automotive offset by declines in construction and printing/packaging markets.
Diversified Industrials Operating EBITDA $200 million, up 8% year-over-year. Margin expanded to 22.9%, an increase of 110 basis points. Growth attributed to favorable mix and productivity.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Product Launches: Introduced upgraded FilmTec nanofiltration elements for municipalities and drinking water utilities, focusing on high-quality water production with lower energy consumption and reduced operating costs.
AI Collaboration: Collaborated with Uncountable, an AI-driven platform, to accelerate product development, improve cycle times, and enhance digital innovation.
Healthcare & Water Technologies Growth: Healthcare sales grew high single digits, driven by medical packaging and biopharma. Water sales faced disruptions in the Middle East but showed strength in industrial water and microelectronics markets.
Diversified Industrials Growth: Aerospace and automotive sectors showed growth, while construction markets remained weak.
Operational Excellence: Improved asset reliability, equipment effectiveness, and on-time delivery through maintenance initiatives, lean execution, and Kaizen activities.
Digital and AI Integration: Expanded use of data-enabled tools for maintenance, defect detection, and asset performance optimization, leading to cost and productivity benefits.
Sustainability Goals: Announced 2035 sustainability goals focusing on sustainable innovation, resilient operations, and community impact, including climate action and renewable energy use.
Capital Allocation: Launched a $275 million accelerated share repurchase program to return cash to shareholders.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Logistics disruptions due to Middle East conflict: The conflict in the Middle East has caused logistics disruptions, particularly impacting sales in the Water business. This has led to challenges in delivering products and maintaining consistent sales in affected regions.
Softness in construction markets: Continued weakness in construction markets has negatively impacted sales in the Building Technologies segment, posing a challenge to growth in this area.
Currency fluctuations: A stronger U.S. dollar has reduced the expected full-year currency benefit, creating headwinds for financial performance.
Geopolitical and macroeconomic headwinds: Potential macroeconomic and geopolitical uncertainties are acknowledged as risks that could impact productivity and operational resilience.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Full Year 2026 Financial Guidance: DuPont has raised its full-year 2026 financial guidance due to strong first-quarter performance and price increases related to the Middle East conflict. The company now expects net sales of approximately $7.185 billion, reflecting 4% organic growth, including 1% from pricing actions. Operating EBITDA is projected at $1.745 billion, and adjusted EPS is expected to range between $2.35 and $2.40 per share, a $0.10 increase from prior guidance.
Second Quarter 2026 Guidance: Net sales are estimated at approximately $1.8 billion, with operating EBITDA of about $430 million and adjusted EPS of $0.59 per share. Organic sales growth is expected to be 3% year-over-year, with mid-single-digit growth in the Healthcare & Water segment and low single-digit growth in the Diversified Industrial segment.
Healthcare & Water Segment Outlook: For the second quarter, organic sales growth is projected in the mid-single digits, driven by strength in medical device, biopharma, and industrial water markets. Full-year growth is expected to be supported by these trends.
Diversified Industrial Segment Outlook: Second-quarter organic sales growth is expected in the low single digits, with continued strength in aerospace and growth in printing and packaging, partially offset by ongoing softness in construction markets.
Currency and Pricing Impact: The full-year guidance includes a reduced currency benefit of less than 1% due to a stronger U.S. dollar and pricing actions to offset higher input costs caused by the Middle East conflict.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Accelerated Share Repurchase Program: DuPont announced the launch of a $275 million accelerated share repurchase under its existing program. This initiative is part of the company's strategic priority to drive disciplined capital allocation by returning cash to shareholders.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Where is the company in the 80/20 implementation process and its impact on the top line?
A:The company is well into the process within the Diversified Industrials portfolio, focusing on four businesses and about 2/3 through the initial study. There has been no impact on the full-year guide for the top line or margin, but over time, they expect margin appreciation with minimal top-line impact.
Q:What is the status of stranded costs for the quarter and the year?
A:The company estimated $30 million of stranded costs to be removed within two years. For the full year, approximately $10 million will be removed, and they are on track to achieve their target.
Q:What is the impact of Middle East logistics issues on the water business?
A:In Q1, $10 million of sales were unable to ship out of the Middle East, causing water sales to decline low to mid-single digits. Adjusting for this, sales would have been flat to slightly down. The materials have since shipped, and the company expects mid-single-digit growth for the full year, with flat performance in the first half and growth in the second half driven by large projects.
Q:What is driving the strong margins in Q1, and how does it compare to the 3-year target?
A:Q1 margins were strong due to a mix (50 basis points) and net productivity (70 basis points). The company is on track to achieve its 3-year target of 150-200 basis points improvement, with an additional 40 basis points of margin expansion expected in the second half.
Q:What is the company's position and strategy in the healthcare segment?
A:The healthcare segment generates $2 billion in sales, with $1.2 billion from Tyvek and the rest from Spectrum and Liveo. The company is well-positioned in medical devices and healthcare packaging and plans to expand through M&A. They recently closed the Aramids transaction, generating $1.1 billion in net proceeds, which provides flexibility for future growth deals.
Q:What is the company's pricing strategy in response to cost pressures?
A:The company has implemented surcharges and price increases to cover incremental costs of approximately $90 million. These measures started in Q2, with a full run rate expected in the second half. Q2 pricing actions are expected to add $25 million to the top line.
Q:What are the Q2 margin expectations and the factors influencing them?
A:Q2 margins are expected to step down to around 24%, with a 30 basis point headwind from price-cost and a 40 basis point headwind from mix. Pricing actions started in April and May, with costs impacting the P&L in Q2.
Q:What is driving strength in the automotive segment?
A:Strength in automotive is primarily due to battery adhesive volumes for EVs, which generate approximately $300 million in sales. The company is outperforming the market due to new volume and wins in the EV space.
Q:What is the company's exposure to the Middle East and its impact on Q2?
A:The company has $300 million in Middle East exposure, with half related to sales into the region and half to sourcing. In Q1, $10 million in sales were impacted, but alternative routes have been found to mitigate disruptions. The Q2 guide accounts for these adjustments.
Q:What is the outlook for the construction market?
A:The construction market is expected to be flat for the full year, with 1% price growth. Q1 saw a low single-digit decline, with weakness in North American residential construction and flat performance in commercial and DIY segments.
Q:What is the company's free cash flow conversion target for 2026?
A:The company targets a free cash flow conversion of greater than 90% for 2026. Working capital dynamics, including inventory management and collections, are being managed to support this goal.
Q:What is the company's strategy for portfolio transformation and M&A?
A:The company is focused on enhancing margins within Diversified Industrials through the 80/20 strategy. They aim to shift the portfolio towards Healthcare & Water, targeting a 2/3, 1/3 balance. They have cash from the Aramids transaction to pursue accretive M&A opportunities.
Q:Review of Unclear Management Responses
A:Management avoided providing a direct answer to the question about potential demand destruction if the Middle East conflict stretches to the end of the year. They stated that their guidance assumes the current situation continues but did not address the potential for increased prices or demand destruction in detail.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI capability
AI platform
Ann Giancristoforo
Aramids ability
CEO event
DuPont record
East conflict
FilmTec nanofiltration
Form VP
Giancristoforo VP
Instructions Ann
Middle East
Officer Chief
RD investment
Relations statement
Safety culture
VP Investor
area
cadence
collaboration
core value
delivery
detail
development
discipline
energy
excellence
generation
improvement
launch
maintenance
product
productivity
reliability
safety
sustainability goal
use
value creation
DD Transcript
DuPont de Nemours, Inc. (DD) Q1 2026 Earnings Call Transcript
Unknown5-5
The earnings call summary presents mixed signals. Positive elements include strong margins, productivity gains, and strategic positioning in the healthcare and automotive segments. However, concerns arise from flat organic sales, construction market weakness, and uncertainties related to Middle East logistics. The Q&A section revealed management's avoidance of addressing potential demand destruction. These factors balance out, suggesting a neutral stock price reaction.
DuPont de Nemours, Inc. (DD) Q4 2025 Earnings Call Transcript
Positive2-10
The earnings call summary and Q&A session reveal strong financial metrics, optimistic guidance, and positive shareholder returns, including a $2 billion share repurchase plan. Despite some concerns about regional sales and margin details, the overall sentiment is positive with raised guidance and strategic initiatives like the reverse osmosis expansion in China. These factors suggest a likely positive stock price movement in the short term.
DuPont de Nemours, Inc. (DD) Q3 2025 Earnings Call Transcript
Positive11-6
The company raised its earnings guidance, announced a significant share repurchase plan, and demonstrated strong performance in key sectors like healthcare and water. The Q&A revealed operational excellence initiatives and a robust M&A pipeline, further supporting growth. Although there are some uncertainties, such as the timing benefit and construction market outlook, the overall sentiment is positive, with strong management confidence in achieving growth targets.
DuPont de Nemours, Inc. (DD) Q2 2025 Earnings Call Transcript
Positive8-5
DuPont's earnings call indicates a positive sentiment with strong growth expectations in healthcare and water, a well-positioned electronics segment, and a strategic focus on M&A in fragmented markets. The Qnity spin-off and effective tariff mitigation further boost confidence. Despite some uncertainties, such as the Aramids divestment, the overall outlook is optimistic, suggesting a positive stock price movement.
DD Slides
DD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
